Original Source(s)
Related Content
Does TYK2/JAK1 Show Potential in Inflammatory Diseases?
Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.
July 6, 2026
-
3 min